YUTRIVO
Live / Registered — Registered (as of 11 Jul 2023)
What this means for you
Registered since 11 Jul 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90495040
- Registration number
- 7102713
- Mark type
- Stylized text
- Filed
- 28 Jan 2021
- Published for opposition
- 22 Mar 2022
- Registered
- 11 Jul 2023
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines
Owner
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
Prosecution history
- 11 Jul 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Jul 2023 — REGISTERED-PRINCIPAL REGISTER
- 08 Jun 2023 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 25 Apr 2023 — NOTICE OF ALLOWANCE CANCELLED
- 08 Jun 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Apr 2023 — TEAS DELETE 1(B) BASIS RECEIVED
- 10 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Nov 2022 — SOU EXTENSION 1 GRANTED
- 08 Nov 2022 — SOU EXTENSION 1 FILED
- 08 Nov 2022 — SOU TEAS EXTENSION RECEIVED
- 17 May 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Mar 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Mar 2022 — PUBLISHED FOR OPPOSITION
- 02 Mar 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Feb 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER